JP2015524484A - 認知の健康および機能を向上させるための植物抽出物 - Google Patents

認知の健康および機能を向上させるための植物抽出物 Download PDF

Info

Publication number
JP2015524484A
JP2015524484A JP2015526726A JP2015526726A JP2015524484A JP 2015524484 A JP2015524484 A JP 2015524484A JP 2015526726 A JP2015526726 A JP 2015526726A JP 2015526726 A JP2015526726 A JP 2015526726A JP 2015524484 A JP2015524484 A JP 2015524484A
Authority
JP
Japan
Prior art keywords
memory
cognitive
learning
function
samp8
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2015526726A
Other languages
English (en)
Japanese (ja)
Other versions
JP2015524484A5 (enExample
Inventor
セディア，マイケル
ハーリンジャー，ケリー
ルイス，ブランドン
フェン，ハリー
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kemin Industries Inc
Original Assignee
Kemin Industries Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kemin Industries Inc filed Critical Kemin Industries Inc
Publication of JP2015524484A publication Critical patent/JP2015524484A/ja
Publication of JP2015524484A5 publication Critical patent/JP2015524484A5/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A61K36/534—Mentha (mint)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Psychiatry (AREA)
  • Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
JP2015526726A 2012-08-09 2013-08-09 認知の健康および機能を向上させるための植物抽出物 Pending JP2015524484A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261681414P 2012-08-09 2012-08-09
US61/681,414 2012-08-09
PCT/US2013/054274 WO2014026081A1 (en) 2012-08-09 2013-08-09 Plant extracts for improving cognitive health and function

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2021001953A Division JP2021066735A (ja) 2012-08-09 2021-01-08 認知の健康および機能を向上させるための植物抽出物

Publications (2)

Publication Number Publication Date
JP2015524484A true JP2015524484A (ja) 2015-08-24
JP2015524484A5 JP2015524484A5 (enExample) 2016-09-29

Family

ID=50066333

Family Applications (4)

Application Number Title Priority Date Filing Date
JP2015526726A Pending JP2015524484A (ja) 2012-08-09 2013-08-09 認知の健康および機能を向上させるための植物抽出物
JP2021001953A Pending JP2021066735A (ja) 2012-08-09 2021-01-08 認知の健康および機能を向上させるための植物抽出物
JP2022196766A Pending JP2023027232A (ja) 2012-08-09 2022-12-09 認知の健康および機能を向上させるための植物抽出物
JP2024208100A Pending JP2025029029A (ja) 2012-08-09 2024-11-29 認知の健康および機能を向上させるための植物抽出物

Family Applications After (3)

Application Number Title Priority Date Filing Date
JP2021001953A Pending JP2021066735A (ja) 2012-08-09 2021-01-08 認知の健康および機能を向上させるための植物抽出物
JP2022196766A Pending JP2023027232A (ja) 2012-08-09 2022-12-09 認知の健康および機能を向上させるための植物抽出物
JP2024208100A Pending JP2025029029A (ja) 2012-08-09 2024-11-29 認知の健康および機能を向上させるための植物抽出物

Country Status (11)

Country Link
US (2) US20140044813A1 (enExample)
EP (1) EP2882443B1 (enExample)
JP (4) JP2015524484A (enExample)
KR (1) KR101947352B1 (enExample)
CN (2) CN111358832A (enExample)
AU (1) AU2013299491B2 (enExample)
BR (1) BR112015002739A2 (enExample)
CA (1) CA2880708C (enExample)
ES (1) ES2715005T3 (enExample)
PL (1) PL2882443T3 (enExample)
WO (1) WO2014026081A1 (enExample)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2021501202A (ja) * 2017-10-30 2021-01-14 ニューロポア セラピーズ インコーポレイテッド 置換フェニルスルホニルフェニルトリアゾールチオンおよびその使用法
JP2021078430A (ja) * 2019-11-20 2021-05-27 株式会社ニップン ロスマリン酸及びカルノシン酸を有効成分とする神経突起伸長誘導作用を有する組成物、並びに、これを含む機能性表示食品
JP2022104122A (ja) * 2020-12-28 2022-07-08 株式会社ニップン オキシトシン関連シグナル活性化剤

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2017507125A (ja) * 2014-01-30 2017-03-16 ケミン、インダストリーズ、インコーポレーテッドＫｅｍｉｎ Ｉｎｄｕｓｔｒｉｅｓ， Ｉｎｃ． 認知機能を向上させるための植物抽出物
CA2961378A1 (en) * 2014-09-15 2016-03-24 Kemin Industries, Inc. Plant extracts for improving cognitive function
WO2016057818A1 (en) * 2014-10-08 2016-04-14 Abbott Laboratories Nutritional compositions comprising an oxidizable component and water-soluble plant extract
ES2951079T3 (es) * 2016-11-11 2023-10-17 Kemin Ind Inc Uso de un extracto de menta verde para mejorar la tasa de neurogénesis
CN106727915B (zh) * 2017-01-18 2020-03-31 云南德彩堂生物医药科技有限公司 一种稳定高效提高记忆的组合物及其制备方法和应用
CN109602759B (zh) * 2019-01-17 2020-10-09 广西医科大学 罗汉松实多糖的用途
KR102421772B1 (ko) * 2019-05-21 2022-07-18 건국대학교 글로컬산학협력단 클로로필 및 로즈마린산을 포함하는 미세먼지에 의해 유발된 신경염증 또는 신경 퇴행성 질환의 예방 또는 치료용 조성물
CN110463846A (zh) * 2019-07-30 2019-11-19 河南科技学院 留兰香提取物在制备抗宠物衰老药物或宠物食品中的应用
EP4608384A1 (en) * 2022-10-27 2025-09-03 Kemin Industries, Inc. Use of a spearmint extract for retina neurotrophism

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2006199666A (ja) * 2005-01-24 2006-08-03 Nagase & Co Ltd 健忘症の予防・治療剤
JP2010510271A (ja) * 2006-11-24 2010-04-02 ディーエスエム アイピー アセッツ ビー．ブイ． ローズマリー抽出物、これらを含有する食品および医薬品組成物、ならびにその使用
JP2011500040A (ja) * 2007-10-17 2011-01-06 コグニス・アイピー・マネージメント・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング レモンバーム抽出物含有食品組成物

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1219509C (zh) * 1998-05-16 2005-09-21 财团法人牧岩生命工学研究所 迷迭香酸及其衍生物用于制备免疫抑制剂药物的用途
JP4629822B2 (ja) * 1999-12-02 2011-02-09 長瀬産業株式会社 神経成長因子合成促進剤
JP2009512711A (ja) * 2005-10-21 2009-03-26 ブレインセルス，インコーポレイティド Ｐｄｅ阻害による神経新生の調節
EP1925213A1 (en) * 2006-11-24 2008-05-28 DSMIP Assets B.V. Dietary and pharmaceutical compositions comprising a sage extract comprising a mixture of tricyclic diterpenes and their derivatives and their uses
WO2008090474A2 (en) * 2007-01-24 2008-07-31 University Of Guelph Production of rosmarinic acid from spearmint and uses thereof
US7972633B2 (en) * 2007-02-07 2011-07-05 Applied Cognitive Sciences, LLC Nutritional supplements for healthy memory and mental function
US9950019B2 (en) * 2009-06-12 2018-04-24 Generex Pharmaceuticals, Inc. Compositions and methods for the prevention and treatment of brain diseases and conditions
CN101773488A (zh) * 2010-02-10 2010-07-14 青岛大学 一种基于迷迭香酸的药物及其在治疗帕金森病中的应用
JP2011256118A (ja) * 2010-06-07 2011-12-22 Kao Corp Ｉｌ−８及びｇｍ−ｃｓｆ発現抑制剤

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2006199666A (ja) * 2005-01-24 2006-08-03 Nagase & Co Ltd 健忘症の予防・治療剤
JP2010510271A (ja) * 2006-11-24 2010-04-02 ディーエスエム アイピー アセッツ ビー．ブイ． ローズマリー抽出物、これらを含有する食品および医薬品組成物、ならびにその使用
JP2011500040A (ja) * 2007-10-17 2011-01-06 コグニス・アイピー・マネージメント・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング レモンバーム抽出物含有食品組成物

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
BEHAVIOURAL BRAIN RESEARCH, vol. 180, JPN6017017429, 2007, pages 139 - 145, ISSN: 0003559415 *
J.AGRIC.FOOD.CHEM., vol. 51, no. 16, JPN6017017430, 2003, pages 4563 - 4569, ISSN: 0003559416 *

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2021501202A (ja) * 2017-10-30 2021-01-14 ニューロポア セラピーズ インコーポレイテッド 置換フェニルスルホニルフェニルトリアゾールチオンおよびその使用法
JP7277473B2 (ja) 2017-10-30 2023-05-19 ニューロポア セラピーズ インコーポレイテッド 置換フェニルスルホニルフェニルトリアゾールチオンおよびその使用法
JP2023100842A (ja) * 2017-10-30 2023-07-19 ニューロポア セラピーズ インコーポレイテッド 置換フェニルスルホニルフェニルトリアゾールチオンおよびその使用法
JP2021078430A (ja) * 2019-11-20 2021-05-27 株式会社ニップン ロスマリン酸及びカルノシン酸を有効成分とする神経突起伸長誘導作用を有する組成物、並びに、これを含む機能性表示食品
JP7330630B2 (ja) 2019-11-20 2023-08-22 株式会社ニップン ロスマリン酸及びカルノシン酸を有効成分とする神経突起伸長誘導作用を有する組成物
JP2022104122A (ja) * 2020-12-28 2022-07-08 株式会社ニップン オキシトシン関連シグナル活性化剤

Also Published As

Publication number Publication date
EP2882443A1 (en) 2015-06-17
US20250009703A1 (en) 2025-01-09
US20140044813A1 (en) 2014-02-13
KR101947352B1 (ko) 2019-02-12
EP2882443A4 (en) 2016-01-06
EP2882443B1 (en) 2019-01-16
CA2880708C (en) 2023-09-26
JP2025029029A (ja) 2025-03-05
JP2021066735A (ja) 2021-04-30
PL2882443T3 (pl) 2019-06-28
BR112015002739A2 (pt) 2017-07-04
ES2715005T3 (es) 2019-05-31
KR20150041654A (ko) 2015-04-16
AU2013299491A1 (en) 2015-02-12
JP2023027232A (ja) 2023-03-01
CA2880708A1 (en) 2014-02-13
CN111358832A (zh) 2020-07-03
CN104684562A (zh) 2015-06-03
WO2014026081A1 (en) 2014-02-13
AU2013299491B2 (en) 2018-03-15

Similar Documents

Publication Publication Date Title
US20250009703A1 (en) Plant extracts for improving cognitive health and function
Farr et al. Effect of botanical extracts containing carnosic acid or rosmarinic acid on learning and memory in SAMP8 mice
Mecocci et al. Antioxidant clinical trials in mild cognitive impairment and Alzheimer's disease
Grundman et al. Antioxidant strategies for Alzheimer's disease
Sharman et al. Assessment of diets containing curcumin, epigallocatechin-3-gallate, docosahexaenoic acid and α-lipoic acid on amyloid load and inflammation in a male transgenic mouse model of Alzheimer's disease: Are combinations more effective?
Mizrahi et al. Pomegranate seed oil nanoemulsions for the prevention and treatment of neurodegenerative diseases: the case of genetic CJD
Zou et al. Neuroprotective effect of peptides extracted from walnut (Juglans Sigilata Dode) proteins on Aβ25-35-induced memory impairment in mice
Bartochowski et al. Dietary interventions to prevent or delay Alzheimer’s disease: what the evidence shows
Smach et al. Effects of sage extract on memory performance in mice and acetylcholinesterase activity
Altinoz et al. Erucic acid, a nutritional PPARδ-ligand may influence Huntington’s disease pathogenesis
Reza-Zaldívar et al. Comprehensive review of nutraceuticals against cognitive decline associated with Alzheimer’s disease
Abu-Taweel et al. Pomegranate juice rescues developmental, neurobehavioral and biochemical disorders in aluminum chloride-treated male mice
Moradi Vastegani et al. Anethole attenuates motor dysfunctions, striatal neuronal activity deficiency and blood brain barrier permeability by decreasing striatal α-synuclein and oxidative stress in rotenone-induced Parkinson’s disease of male rats
Attia et al. Protective role of functional food in cognitive deficit in young and senile rats
Bessetti et al. Broccoli for the Brain: A Review of the Neuroprotective Mechanisms of Sulforaphane
Meng et al. Comparative analyses of DHA‐phosphatidylcholine forage and liposomes on alzheimer's disease in SAMP8 mice
CA2838976C (en) Dha and epa in the reduction of oxidative stress
Yan et al. Dietary beta-hydroxybutyrate is superior to a ketogenic diet to improve behavior and abnormal myelination in a mouse model of NMDA receptor deficiency
Marcos et al. Cognition and Omega-3 Fatty Acids-A Narrative Review of the Literature
Marques Role of nutrition in adult neurogenesis
Vaibhav et al. Delineation of Neuroprotective Effects and Possible Benefits of AntioxidantsTherapy for the Treatment of Alzheimer’s Diseases by Targeting Mitochondrial-Derived Reactive Oxygen Species: Bench to Bedside
Farooqui Beneficial effects of extra virgin olive oil (n-9 fatty acids) on neurological disorders
Andrade Retarding brain ageing and cognitive decline
Maczurek et al. Lipoic acid as a novel treatment for mild cognitive impairment and early-stage Alzheimer’s disease
Faldu Neuropharmacological actions of Celastrus Paniculatus Wills

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20160805

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20160805

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20170518

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20170728

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20171018

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20171116

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20171116

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20180425

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20180725

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20180725

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20181029

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20190226

C60 Trial request (containing other claim documents, opposition documents)

Free format text: JAPANESE INTERMEDIATE CODE: C60

Effective date: 20190226

A911 Transfer to examiner for re-examination before appeal (zenchi)

Free format text: JAPANESE INTERMEDIATE CODE: A911

Effective date: 20190306

C21 Notice of transfer of a case for reconsideration by examiners before appeal proceedings

Free format text: JAPANESE INTERMEDIATE CODE: C21

Effective date: 20190307

A912 Re-examination (zenchi) completed and case transferred to appeal board

Free format text: JAPANESE INTERMEDIATE CODE: A912

Effective date: 20190412

C211 Notice of termination of reconsideration by examiners before appeal proceedings

Free format text: JAPANESE INTERMEDIATE CODE: C211

Effective date: 20190416

C22 Notice of designation (change) of administrative judge

Free format text: JAPANESE INTERMEDIATE CODE: C22

Effective date: 20191003

C22 Notice of designation (change) of administrative judge

Free format text: JAPANESE INTERMEDIATE CODE: C22

Effective date: 20200707

C13 Notice of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: C13

Effective date: 20200708

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20201007

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20201106

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20201208

C23 Notice of termination of proceedings

Free format text: JAPANESE INTERMEDIATE CODE: C23

Effective date: 20210203

C03 Trial/appeal decision taken

Free format text: JAPANESE INTERMEDIATE CODE: C03

Effective date: 20210303

C30A Notification sent

Free format text: JAPANESE INTERMEDIATE CODE: C3012

Effective date: 20210303